id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-P-0134-0012,FDA,FDA-2000-P-0134,Response Letter from FDA CFSAN to W. Schultz and C. Angulo,Other,Agency Response,2019-11-18T05:00:00Z,2019,11,2019-11-18T05:00:00Z,,2019-11-18T16:14:47Z,,0,0,0900006484173cf9
FDA-2000-P-0134-0011,FDA,FDA-2000-P-0134,Final Response from FDA CFSAN to Zuckerman Spaeder LLP,Other,Agency Response,2019-11-06T05:00:00Z,2019,11,2019-11-06T05:00:00Z,,2019-11-06T19:45:20Z,,0,0,0900006484125675